| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |